The latest from DatChem.
Media features, milestones and the science behind better, earlier detection.
DatChem on the news.
9News · Early Detection feature on DatChem
Recent milestones.
Siemens Healthineers LOI signed
A letter of intent to launch DatChem products on Siemens MRI systems formalises a relationship 25 years in the making.
Longitudinal breast study completed
A 12-year validation study reports 32 of 33 cancers correctly predicted in the high-risk cohort, all on the very first scan.
PTSD & blast trial completed
A clinical trial funded by the USA CTTSO records up to five dysfunctional neural pathways, an objective first.
A clear path to FDA
With three clinical sites live across Australia, Europe and the US, DatChem advances toward FDA, TGA and EMA approval.
ADHD trial on the horizon
Building on the PTSD breakthrough, an ADHD clinical trial is next, beginning in Australia with global intent.
Portfolio grows across three regions
Nine granted patents and twelve pending applications now span the US, EU and Australia.
Following the DatChem story?
For media, clinical or partnership enquiries, our team would be glad to help.